| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/11/2013 | CA2850635A1 Methods for treating a stroke-related sensorimotor impairment using aminopyridines |
| 04/11/2013 | CA2850082A1 Ethynyl derivatives as mglur5 allosteric modulators |
| 04/11/2013 | CA2849754A1 Sensation-improving agent |
| 04/11/2013 | CA2849751A1 Novel chiral n-acyl-5,6,7,(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective nk-3 receptor antagonists, pharmaceutical composition, methods for use in nk-3 receptor mediated disorders and chiral synthesis thereof |
| 04/10/2013 | EP2578574A1 Optically active dibenzylamine derivative, and manufacturing method for same |
| 04/10/2013 | EP2578235A2 Liquid formulation of G-CSF conjugate |
| 04/10/2013 | EP2578232A1 Treatment drug for autoimmune diseases and allergic diseases |
| 04/10/2013 | EP2578224A1 Cell growth-promoting peptide and use thereof |
| 04/10/2013 | EP2578223A1 Pharmaceutical composition for treating drug addiction |
| 04/10/2013 | EP2578219A1 Novel indazole derivative or salt thereof, manufacturing intermediate therefor, antioxidant using same, and use for an indazole derivative or salt thereof |
| 04/10/2013 | EP2578217A1 Sympatholytic agent, and cosmetic, food and sundry containing same |
| 04/10/2013 | EP2578216A1 Methods of treating fragile x syndrome |
| 04/10/2013 | EP2578212A1 Compound inhibiting activation of the enzyme erk1/2 for use in the treatment of neurogenerative illnesses |
| 04/10/2013 | EP2576624A1 Recombinant human g-csf dimer and use thereof for the treatment of neurological diseases |
| 04/10/2013 | EP2576617A2 MONOCLONAL ANTIBODIES TARGETING Aß OLIGOMERS |
| 04/10/2013 | EP2576552A2 Benzoquinolone inhibitors of vmat2 |
| 04/10/2013 | EP2576543A1 Pyrazole compounds as sigma receptor inhibitors |
| 04/10/2013 | EP2576542A1 Ccr2 receptor antagonists |
| 04/10/2013 | EP2576540A2 Heteroaryl compounds and methods of use thereof |
| 04/10/2013 | EP2576538A1 New ccr2 antagonists |
| 04/10/2013 | EP2576520A1 Radiolabeled compounds and methods thereof |
| 04/10/2013 | EP2576509A1 Flufenoxine derivatives for the treatment and prevention of amiloyd pathologies |
| 04/10/2013 | EP2576507A1 Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application |
| 04/10/2013 | EP2576496A1 Nicotinic receptor non-competitive antagonists |
| 04/10/2013 | EP2575893A1 Conjugates for the prevention or treatment of nicotine addiction |
| 04/10/2013 | EP2575876A1 Multivalent synthetic nanocarrier vaccines |
| 04/10/2013 | EP2575853A1 Methods and pharmaceutical composition for the treatment of a feeding disorder with early-onset in a patient |
| 04/10/2013 | EP2575828A1 Xenon-based inhalable drug for preventing addiction relapses in humans |
| 04/10/2013 | EP2575825A2 Compositions and methods for treating depression |
| 04/10/2013 | EP2575820A1 Controlled release dosage form comprising quetiapine |
| 04/10/2013 | EP2575817A1 Organic compounds |
| 04/10/2013 | EP2575815A1 Glycine transporter-1 inhibitors, methods of making them, and uses thereof |
| 04/10/2013 | EP2575807A1 Formulation based on sulpiride and a synergistic homeopathic composition for treatment of depressive syndrome |
| 04/10/2013 | EP2575792A1 Biguanide compounds and its use for treating cancer |
| 04/10/2013 | EP2575773A2 Synthetic nanocarrier combination vaccines |
| 04/10/2013 | EP2575454A1 Naphthalene carboxamide m1 receptor positive allosteric modulators |
| 04/10/2013 | EP2356105B1 ( pyrrolidin-2 -yl) phenyl derivatives for use in the treatment of pain |
| 04/10/2013 | CN103038238A Crystal of thienopyrimidine derivative |
| 04/10/2013 | CN103038229A Heteroaryl compounds and methods of use thereof |
| 04/10/2013 | CN103038218A Condensed ring pyridine compound |
| 04/10/2013 | CN103037879A Method for preparing novel processed ginseng or an extract thereof, the usually minute ginsenoside content of which is increased |
| 04/10/2013 | CN103037872A Composition for treatment of damaged part |
| 04/10/2013 | CN103037864A Compositions and methods for the treatment of addiction, psychiatric disorders, and neurodegenerative disease |
| 04/10/2013 | CN103037863A Method for treating schizophrenia and related diseases |
| 04/10/2013 | CN103037841A Intravenous curcumin and derivatives for treatment of neurodegenerative and stress disorders |
| 04/10/2013 | CN103033587A Detection method of medicament for treating epilepsia hyperspasmia, infantile convulsions and prosopospasm |
| 04/10/2013 | CN103030654A Micromolecular c-Met protein kinase inhibitor |
| 04/10/2013 | CN103030619A C-crystal-form 5-methyl-7-methoxyiso-flavone and preparation method, pharmaceutical compositions and application of C-crystal-form 5-methyl-7-methoxyiso-flavone |
| 04/10/2013 | CN103030617A Glucopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture |
| 04/10/2013 | CN103028122A Application of miR-214 to preparation of product for preventing or treating alzheimer disease |
| 04/10/2013 | CN103028121A miR-21 compound of target microglial cell and preparation method and application of miR-21 compound |
| 04/10/2013 | CN103028119A Application of miR-132 in preparation of drug for treating parkinsonism |
| 04/10/2013 | CN103028113A Varicella zoster virus vaccine |
| 04/10/2013 | CN103028110A Novel use of antisecretory factor |
| 04/10/2013 | CN103028109A Traditional Chinese medicine agent for treating Alzheimer disease |
| 04/10/2013 | CN103028105A Traditional Chinese medicine composition for treating headache |
| 04/10/2013 | CN103028095A Preparation technology and production method of integrated new dosage form of dry ginger and Radix aconiti lateralis preparata decoction |
| 04/10/2013 | CN103028087A Traditional Chinese medicine composition for treating rectal cancer |
| 04/10/2013 | CN103028081A Traditional Chinese medicine composition for treating migraine |
| 04/10/2013 | CN103028055A Traditional Chinese medicine for treating migraine |
| 04/10/2013 | CN103028038A Smoking control tablet |
| 04/10/2013 | CN103028036A Capsule for improving sleep and preparation method thereof |
| 04/10/2013 | CN103028034A Pharmaceutical composition for treating insomnia and preparation method |
| 04/10/2013 | CN103028018A Preparation method of traditional Chinese medicine prescription for treating prosopalgia |
| 04/10/2013 | CN103027993A Traditional Chinese medicine health-care cigarette having functions of clearing away heat and reducing lipid |
| 04/10/2013 | CN103027967A Preparation method of Radix Serratulae Chinensis extract |
| 04/10/2013 | CN103027966A Preparation technology and production method of integrative new dosage form of Radix Puerariae decoction for flesh resolving |
| 04/10/2013 | CN103027951A Purification method of cortex mori total flavonoids |
| 04/10/2013 | CN103027923A Pharmaceutical composition suitable for mild disease of senile vascular dementia |
| 04/10/2013 | CN103027917A Application of Houttuynoid C in preparation of drug for treating alzheimer disease |
| 04/10/2013 | CN103027916A Application of Houttuynoid D in preparation of antidepressant drug |
| 04/10/2013 | CN103027892A Penfluridol self-micro-emulsifying nano composition and preparation method thereof |
| 04/10/2013 | CN103027138A Tea for enlivening spleens and production method of tea |
| 04/10/2013 | CN102643733B Health care wine for fatigue endurance and sleep regulation and method for preparing health care wine |
| 04/10/2013 | CN102485231B Discocleidion sufescens Pax et Hoffm. extract, preparation method thereof and purpose thereof |
| 04/10/2013 | CN102399666B Ginseng wine and production technology thereof |
| 04/10/2013 | CN102379910B New application for pien tze huang and preparation thereof in aspect of protecting memory function and resisting cerebral ischemia |
| 04/10/2013 | CN102342927B Method for extracting silkworm chrysalis extract |
| 04/10/2013 | CN102274196B 盐酸纳洛酮冻干粉针剂及其制备方法 Naloxone freeze-dried powder and its preparation method |
| 04/10/2013 | CN102266428B Anti-ageing Chinese medicinal composition and preparation method and application thereof |
| 04/10/2013 | CN102240279B Piglet soothing agent and preparation method and application thereof |
| 04/10/2013 | CN102228449B Gastrodin chronopharmaceutical medicine delivery preparation |
| 04/10/2013 | CN102225171B Traditional Chinese medicine soft capsule for treating headache and preparation method thereof |
| 04/10/2013 | CN102219752B Crystal form D of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide |
| 04/10/2013 | CN102188420B Levetiracetam medicinal composition and preparation method thereof |
| 04/10/2013 | CN102178937B Pharmaceutical composition for protecting liver and benefiting spleen and preparation method thereof |
| 04/10/2013 | CN102178751B Brain clearing and pain relieving preparation |
| 04/10/2013 | CN102178658B Lappaconitine hydrobromide orally disintegrating tablets and preparation method thereof |
| 04/10/2013 | CN102144963B Citicoline sodium glucose injecta and preparation process thereof |
| 04/10/2013 | CN102140469B Human miR (microRNA)-1233 antisensenucleic acid and application thereof |
| 04/10/2013 | CN102010425B 1,4-disulfide-7-azaspiro [4,4] nonane-8-carboxylic acid derivative histone deacetylase inhibitor and application thereof |
| 04/10/2013 | CN102002493B Application of small RNA-326 in preparation of medicament |
| 04/10/2013 | CN101967186B Encephalitis virus protein and code gene and application thereof |
| 04/10/2013 | CN101967185B Encephalitis virus protein as well as coding gene and application thereof |
| 04/10/2013 | CN101962384B Chromene compounds, a process for their preparation and pharmaceutical compositions containing them |
| 04/10/2013 | CN101897964B Medicament for preventing autoimmune disease |
| 04/10/2013 | CN101744969B Medicinal composition for treating insomnia and preparation method thereof |
| 04/10/2013 | CN101716149B Precursor medicinal preparation |
| 04/10/2013 | CN101684118B Use of tricyclic compounds as glycine transport inhibitors |
| 04/10/2013 | CN101664552B Stabilization of hypoxia inducible factor (HIF) alpha |